Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CTSS | P25774 | 2/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | LAP3 | P28838 | 2/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8610024 | 0.84 | FOLH1 (0.51) | FOLH1ALDH1A1CTSSCTSKLAP3 | |
| SCHEMBL8610073 | 0.83 | L3MBTL1 (0.45) | FOLH1ALDH1A1MEN1KMT2A | |
| SCHEMBL8613767 | 0.82 | FOLH1 (0.49) | FOLH1ALDH1A1CTSSCTSKLAP3 | |
| SCHEMBL8613294 | 0.82 | FOLH1 (0.49) | FOLH1ALDH1A1CTSSCTSKLAP3 | |
| SCHEMBL8895941 | 0.80 | CTSB (0.56) | CTSSCTSKCTSLCTSBMEN1 | |
| SCHEMBL8608760 | 0.80 | FOLH1 (0.44) | FOLH1ALDH1A1LAP3 | |
| SCHEMBL8895944 | 0.79 | CTSL (0.45) | CTSSCTSKCTSLCTSBMEN1 | |
| SCHEMBL8612045 | 0.71 | FOLH1 (0.52) | FOLH1ALDH1A1CTSSCTSKLAP3 | |
| SCHEMBL8612042 | 0.71 | FOLH1 (0.52) | FOLH1ALDH1A1CTSSCTSKLAP3 | |
| SCHEMBL9830222 | 0.71 | ALDH1A1 (0.58) | ALDH1A1CTSSCTSKMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0457195-B1 | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-04-15 | — | — | EP | disclosed |
| US-5656604-A | HYPOTENSIVE AGENT; ENDOTHELIN ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-12 | — | — | US | disclosed |
| US-5430022-A | Endothelin antagonists; hypotensive agents; treatment for angina pectoris, brain disorders, asthma, renal failure | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-04 | — | — | US | disclosed |
| US-5284828-A | Hypotensive agents | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 1994-02-08 | — | — | US | disclosed |